Medicus Pharma Ltd. (MDCX)
NCM · Drug Manufacturers - General
Sources: Yahoo Finance (quote, statistics) · SEC EDGAR (filings, insider trades, 13F holders) · company filings & press wires
Company overview
Medicus Pharma Ltd., a biotech/life sciences company, focuses on developing clinical development programs of therapeutic assets in the United States. It is developing SKNJCT-003, which is in Phase 2 study for the treatment of basal cell carcinoma of the skin. The company has a strategic collaboration with the Gorlin Syndrome Alliance to access to SKINJECT in Patients with Gorlin Syndrome. The company was formerly known as Interactive Capital Partners Corporation and changed its name to Medicus Pharma Ltd. in September 2023. The company was incorporated in 2008 and is headquartered in West Conshohocken, Pennsylvania.
Peers in Drug Manufacturers - General
All in industry →Eli Lilly and Company
Johnson & Johnson
AbbVie Inc.
AstraZeneca PLC
Merck & Co., Inc.
Novartis AG
Amgen Inc.
Gilead Sciences, Inc.
Novo Nordisk A/S
Pfizer Inc.
Recent press releases
Medicus Pharma Ltd. has not issued a press release in this window.
SEC filings
All filings →Medicus Pharma Ltd. has not filed an SEC document in this window.
Insider trades
All insider trades →Medicus Pharma Ltd. has no reported insider trades in the last 90 days.
Institutional holders
All holders →No 13F holdings have been reported for Medicus Pharma Ltd. in this window.
People at Medicus Pharma Ltd.
All people →Quarterly financials
Full financials →No quarterly financials have been ingested for Medicus Pharma Ltd..